Vimarsana
Biggest News Aggregation in the World

Page 20 - Pfizer Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pfizer Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pfizer Ventures Today - Breaking & Trending Today

ImmunOs Therapeutics Appoints Steve Coats, PhD, as Chief Development Officer - Vimarsana News

ImmunOs Therapeutics Appoints Steve Coats, PhD, as Chief Development Officer

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Parthenon Therapeutics Raises $65M in Series A Funding - Vimarsana News

Parthenon Therapeutics Raises $65M in Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Sending a Message: ReCode is Delivering Genetic Medicines with Lipid Nanoparticle - Vimarsana News

Sending a Message: ReCode is Delivering Genetic Medicines with Lipid Nanoparticle

GEN Edge speaks with ReCode Therapeutics CEO & President David J. Lockhart, PhD, to discuss how the company came together through a merger, and how it plans to harness lipid nanoparticles (LNPs) for genetic medicines.

Related Topics:
Pfizer Ventures
Healthcare & Life Sciences Private Equity Deal Tracker: Carlyle and Other Funds Acquire Saama Technologies | McGuireWoods LLP - Vimarsana News

Healthcare & Life Sciences Private Equity Deal Tracker: Carlyle and Other Funds Acquire Saama Technologies | McGuireWoods LLP

Funds led by Carlyle have acquired a majority stake in Saama Technologies, according to a news release. The investment is valued at up to $430 million.

Saama Raises Up To $430M Investment - Vimarsana News

Saama Raises Up To $430M Investment

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!